FIELD: medicine, vaccines. SUBSTANCE: suspension of validated diploid cells of culture L-68 at concentration 200 000-300 000 cells/ml is infected with vaccine strain of measles virus. Multiple of infection is 0.1-0.01 TCD 50/cell. Infected cells are cultured at 32-35 C. After monolayer formation inert proteins of cultured medium are removed by 6-fold washing out with nutrient medium. Virus-containing liquid is collected at least once in every 24 h. Viral pourings at titer 5-6 lg TCD 50/0.5 ml and at protein content 16 mcg/ml, not above, are combined. Cellular detritus is removed by filtration, stabilized with sorbitol-gelatin and subjected for lyophilic drying. EFFECT: improved method of vaccine preparing. 3 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1998 |
|
RU2140288C1 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1996 |
|
RU2123331C1 |
METHOD OF PREPARING LIVE MEASLES VACCINE FOR ORAL USING AND METHOD OF IMMUNIZATION AGAINST MEASLES | 1997 |
|
RU2133625C1 |
METHOD FOR OBTAINING MICROCAPSULATED FORM OF MEASLES VACCINE FOR PERORAL INTAKE | 2001 |
|
RU2210361C2 |
METHOD OF PREPARING MEASLES VIRUS AND SUPPORTING MEDIUM FOR ITS CULTURING (VARIANTS) | 1996 |
|
RU2129607C1 |
LIVE VACCINE FOR MEASLES PROPHYLAXIS | 1996 |
|
RU2129876C1 |
LIVE CULTURAL ANTIMEASLES VACCINE | 1998 |
|
RU2144369C1 |
TABLETED LIVE RECOMBINANT BIVACCINE "REVAKS VKT" AGAINST NATURAL SMALLPOX AND HEPATITIS B AND METHOD FOR ITS PREPARING | 2002 |
|
RU2242246C2 |
METHOD OF REGENERATION OF VIRUS MEASLES VACCINE STRAIN | 1995 |
|
RU2088662C1 |
METHOD OF MEASLES VIRUS CULTIVATION | 1994 |
|
RU2053297C1 |
Authors
Dates
1998-06-10—Published
1995-10-03—Filed